EMISPHERE TECHNOLOGIES INC Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2009-02: Study NCT01312831; Company role Lead sponsor; Phase Not applicable; Status Completed.
- 2008-05: Study NCT01311739; Company role Lead sponsor; Phase Not applicable; Status Completed.
- 2001-10: Study NCT00982254; Company role Collaborator; Phase Phase 1; Status Completed.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2009-02 | NCT01312831 Efficacy and Safety Study of Oral Eligen® B12 in Subjects With Low Serum Cobalamin | Lead sponsor | Not applicable | Completed | Vitamin B 12 Deficiency | 49 | 2010-12 |
| 2008-05 | NCT01311739 Oral Cyanocobalamin (Eligen B12) Bioavailability Study | Lead sponsor | Not applicable | Completed | Healthy | 20 | 2008-06 |
| 2001-10 | NCT00982254 Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes | Collaborator Lead: Profil Institut für Stoffwechselforschung GmbH | Phase 1 | Completed | Type 2 Diabetes | 10 |